These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 9192821
1. Alteration in gamma-glutamyl transpeptidase activity and messenger RNA of human prostate carcinoma cells by androgen. Ripple MO, Pickhardt PA, Wilding G. Cancer Res; 1997 Jun 15; 57(12):2428-33. PubMed ID: 9192821 [Abstract] [Full Text] [Related]
2. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells. Schatten H, Ripple M, Balczon R, Weindruch R, Chakrabarti A, Taylor M, Hueser CN. J Cell Biochem; 2000 Jan 15; 76(3):463-77. PubMed ID: 10649443 [Abstract] [Full Text] [Related]
3. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. Ripple MO, Henry WF, Rago RP, Wilding G. J Natl Cancer Inst; 1997 Jan 01; 89(1):40-8. PubMed ID: 8978405 [Abstract] [Full Text] [Related]
4. Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cells. Ripple MO, Wilding G. Cancer Res; 1995 Oct 01; 55(19):4234-6. PubMed ID: 7671226 [Abstract] [Full Text] [Related]
5. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z. Clin Cancer Res; 2001 Sep 01; 7(9):2941-8. PubMed ID: 11555613 [Abstract] [Full Text] [Related]
6. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Obrador E, Carretero J, Ortega A, Medina I, Rodilla V, Pellicer JA, Estrela JM. Hepatology; 2002 Jan 01; 35(1):74-81. PubMed ID: 11786961 [Abstract] [Full Text] [Related]
7. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H. Br J Cancer; 1999 Sep 01; 81(2):242-51. PubMed ID: 10496349 [Abstract] [Full Text] [Related]
8. Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase. Shao C, Wang Y, Yue HH, Zhang YT, Shi CH, Liu F, Bao TY, Yang ZY, Yuan JL, Shao GX. J Androl; 2007 Sep 01; 28(6):804-12. PubMed ID: 17581945 [Abstract] [Full Text] [Related]
9. E2F activity is biphasically regulated by androgens in LNCaP cells. Hofman K, Swinnen JV, Verhoeven G, Heyns W. Biochem Biophys Res Commun; 2001 Apr 27; 283(1):97-101. PubMed ID: 11322773 [Abstract] [Full Text] [Related]
10. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L. Cancer Res; 2001 Feb 01; 61(3):1196-206. PubMed ID: 11221851 [Abstract] [Full Text] [Related]
11. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells. Lin MF, DaVolio J, Garcia-Arenas R. Cancer Res; 1992 Sep 01; 52(17):4600-7. PubMed ID: 1380886 [Abstract] [Full Text] [Related]
12. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS. Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738 [Abstract] [Full Text] [Related]
13. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2. Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G. Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781 [Abstract] [Full Text] [Related]
14. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM. Cancer Res; 2001 Apr 01; 61(7):2892-8. PubMed ID: 11306464 [Abstract] [Full Text] [Related]
15. gamma-Glutamyl transpeptidase in normal and neoplastic prostate glands. Frierson HF, Theodorescu D, Mills SE, Hanigan MH. Mod Pathol; 1997 Jan 01; 10(1):1-6. PubMed ID: 9021720 [Abstract] [Full Text] [Related]
16. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Seth D, Shaw K, Jazayeri J, Leedman PJ. Br J Cancer; 1999 May 01; 80(5-6):657-69. PubMed ID: 10360641 [Abstract] [Full Text] [Related]
17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A, Fraizer GC, Piantanelli L, Saunders GF. Anticancer Res; 2001 May 01; 21(1A):1-10. PubMed ID: 11299720 [Abstract] [Full Text] [Related]
18. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line. el-akawi Z, Zdanowicz J, Creaven PJ, Abu-hadid M, Perez R, Pendyala L. Oncol Res; 1996 May 01; 8(10-11):415-23. PubMed ID: 9114434 [Abstract] [Full Text] [Related]
19. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. Gleave M, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, Goldie J. Clin Cancer Res; 1999 Oct 01; 5(10):2891-8. PubMed ID: 10537358 [Abstract] [Full Text] [Related]
20. Hypoxia increases androgen receptor activity in prostate cancer cells. Park SY, Kim YJ, Gao AC, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park EM, Yoon SY, Park YM. Cancer Res; 2006 May 15; 66(10):5121-9. PubMed ID: 16707435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]